Cargando…
Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
Angiotensin converting enzyme 2 (ACE2), is a monocarboxypeptidase which metabolizes several peptides including the degradation of Ang II, a peptide with vasoconstrictive/proliferative/effects, to generate Ang 1–7, which acting through its receptor Mas exerts vasodilatory/anti-proliferative actions....
Autores principales: | Patel, Vaibhav B., Putko, Brendan, Wang, Zuocheng, Zhong, Jiu-Chang, Oudit, Gavin Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185729/ https://www.ncbi.nlm.nih.gov/pubmed/32362932 http://dx.doi.org/10.1016/j.ddstr.2013.11.001 |
Ejemplares similares
-
Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19
por: Oudit, Gavin Y, et al.
Publicado: (2020) -
Angiotensin Converting Enzyme 2 - at the Heart of the COVID-19 pandemic
por: Oudit, Gavin Y., et al.
Publicado: (2023) -
Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors 1 and 2
por: Clayton, Daniel, et al.
Publicado: (2015) -
Loss of Angiotensin-Converting Enzyme-2 Leads to the Late Development of Angiotensin II-Dependent Glomerulosclerosis
por: Oudit, Gavin Y., et al.
Publicado: (2006) -
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
por: Ni, Wentao, et al.
Publicado: (2020)